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Abstract: Introduction: Crohn’s disease (CD) is a chronic intestinal ailment with a multifactorial etiology, whose in-
cidence has increased during the last three decades. Recently, a role for mesenteric fat has been proposed in CD 
pathophysiology, since fat hypertrophy is detected nearby the affected intestinal area; however, there are few stud-
ies on this aspect. Aim: To evaluate inflammatory activity in intestinal mucosa and mesenteric fat tissue of patients 
with CD and controls. Materials and Methods: Ten patients with ileocecal CD and 16 patients with non-inflammatory 
disease (control groups) were studied. The specimens were snap-frozen and the expression of TLR-4, F4/80, IL1-β 
and IL-6 were determined by immunoblot of protein extracts. TLR4 RNA level were measured using RT-PCR. The t 
Test was applied (p<0.05). The local ethical committee approved the study. Results: The intestinal mucosa of CD 
group had significantly higher protein levels of TLR-4, F4/80, IL-1β and IL-6 than the controls. The gene expression 
of TLR4 was lower in the intestinal mucosa of CD compared to the control group. Regard the mesenteric fat tissue, 
there was no statistical difference related to TLR-4, F4/80, IL-1β and IL-6 proteins expression. Conclusions: These 
findings may result from an up-regulation of macrophage activation and intracellular pathways activated by bacte-
rial antigens, which are more important in intestinal mucosa than fat tissue in CD patients. This may represent an 
anomalous regulation of innate immunity and could contribute to the production of proinflammatory mediators and 
disease development.
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Introduction
The increasing incidence of inflammatory bowel 
disease (IBD), particularly Crohn’s disease (CD) 
and ulcerative colitis (UC), has raised queries 
regarding the pathogenesis and factors poten-
tially involved in the onset of these diseases. 
CD and UC are multifactorial chronic intestinal 
diseases, which occur mainly in the second and 
third decades of life [1].
Macrophages are key cells involved in IBD, 
since they are part of the innate immune sys-
tem at the interface with the external environ-
ment, and are responsible for the release of 
various cytokines such as TNF-α and IFN-γ. 
Once released, these proinflammatory cyto-
kines induce the activation of their respective 
receptors triggering the activation of an intra-
cellular signaling cascade ultimately leading to 
the activation of nuclear transcription factors 
NF-КB and STAT-1, which control the transcrip-
tion of inflammatory factors [2, 3].
The membrane receptors TLRs (Toll-like recep-
tors) that mediate the recognition of antigens of 
the intestinal lumen as lipopolysaccharide 
(LPS), peptideoglycan (PGN) or flagellin (Flag) 
were also associated with CD due to the activa-
tion of NF-КB via MyD88, thereby increasing 
the production of proinflammatory cytokines 
such as IL-1β, IL-6, IL-8 and susceptibility to 
invasion by pathogens in the lamina propria, 
thus perpetuating the inflammatory process [4, 
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5]. In addition, the intestinal epithelium is able 
to express various TLRs, especially TLR4, veri-
fied in IBD [6, 7].
Although there is phenotypic variation in surgi-
cal specimens from CD patients, macroscopic 
aspects are notorious, especially with regard to 
thickening of the mesenteric fat next to the 
affected intestinal area [8-10]. As macrophages 
and epithelial cells, adipocytes from normal 
individuals are able to synthesize various proin-
flammatory and anti-inflammatory cytokines, 
and fat hormones. Indeed, adipocytes can 
express TLR4 for the recognition of local or sys-
temic bacterial antigens, and can express 
CD14 protein that assists in binding of LPS to 
TLR4 [11, 12].
There have been few studies of mesenteric fat 
in CD discussing this aspect [13-18]. Therefore, 
in order to compare the inflammatory activity in 
fat and intestinal tissue between CD patients 
and controls we employed assays to determine 
the expression of proteins related to innate 
immune system (F4/80, TLR4) and of pro-
inflammatory proteins.
Materials and methods
Mucosal biopsies were taken from 10 patients 
with ileocecal CD [median age 34.9 (range, 
14-60) years; male 50%; female 50%]. The 
biopsies from intestinal mucosa and mesen-
teric fat tissue of patients with CD were desig-
nated as ICD and FCD groups respectively. The 
presence of disease activity was assessed by 
colonoscopy before surgery and all patients 
had Crohn’s disease activity index (CDAI) [19] 
more than 250 points. The controls groups 
were composed of eight patients who under-
went to retosigmoidectomy for non-inflammato-
ry disease (megacolon), with normal distal 
ileum (ileum mesenteric fat tissue control – FC 
group) [median age 55.6 (range, 39-70) years; 
male 62.5%; female 37.5%], and eight patients 
with normal ileocolonoscopy (intestinal tissue 
control – IC group) [median age 50.4 (range, 
33-60) years; male 37.5%; female 62.5%]. The 
features of mesenteric fat are shown in Figure 
1.
The study was performed in accordance with 
the Declaration of Helsinki, and was approved 
by the local Ethical Committee. All biopsies 
were taken after informed consent from the 
patients. The study was carried out at the State 
University of Campinas, Colorectal Surgery 
Unit, and at the Cell Signaling Laboratory of the 
Department of Internal Medicine.
Biopsies from the mucosa of the terminal ileum 
and from mesenteric fat tissue near the intesti-
nal affected area were snap-frozen in liquid 
nitrogen and stored at -80°C until use. 
Western blotting analysis
For total protein extract preparation, the frag-
ments were homogenized in solubilization buf-
fer at 4°C [1% Triton X-100, 100mM Tris-HCl 
(pH 7.4), 100mM sodium pyrophosphate, 
100mM sodium fluoride, 10mM EDTA, 10mM 
sodium orthovanadate, 2.0mM phenylmethyl-
sulfonyl fluoride (PMSF), and 0.1mg aprotinin/
ml] with a Polytron PTA 20S generator (model 
PT 10/35; Brinkmann Instruments, Westbury, 
NY) operated at maximum speed for 30 sec. 
The material was centrifugated (20 min at 
110000 rpm at 4°C). The protein concentra-
tions of the supernatants were determined by 
the Bradford dye binding method [20]. Aliquots 
of the resulting supernatants containing 50μg 
total proteins were separated by SDS-PAGE, 
transferred to nitrocellulose membranes, 
blocked with BSA (bovine serum albumin), and 
blotted with anti-F4/80, anti-TLR-4, IL-1β and 
IL-6 antibodies [21].
Reagents for SDS-PAGE and immunoblotting 
were from Bio-Rad Laboratories (Richmond, 
CA). Phenylmethylsulfonyl fluoride, aprotinin, 
Triton X-100, Tween 20, glycerol were from 
Sigma (St. Louis, MO). Nitrocellulose paper 
(BA85, 0.2μm) was from Amersham (Aylesbury, 
Figure 1. Surgical aspects of creeping fat in ileum 
with Crohn’s disease.
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UK). The anti-F4/80 (sc-71085, rat monoclo-
nal), anti-TLR4 (sc-10741, rabbit polyclonal), 
anti-IL-1β (sc-1252, goat polyclonal) and anti-
IL-6 (sc-1266, goat polyclonal) antibodies were 
purchased from Santa Cruz Biotechnology, Inc. 
(Santa Cruz, CA). The protein molecular weight 
was assessed by the PageRulerTM from 
Fermentas (MD, USA).
The signal was detected by chemiluminescent 
reaction (SuperSignal®West Pico Chemilumine 
-scent Substrate from Pierce Biothecnology, 
Inc. Rockford).
All numerical results are 
expressed as the mean ± 
SD of the indicated num-
ber of experiments. The 
results of blots are pre-
sented as direct compari-
sons of bands in autora-
diographs and quantified 
by densitometry using the 
Gel-Pro Analyzer 6.0 soft-
ware (Exon-Intron Inc., 
Farrell, MD). The readings 
of the bands were stan-
dardized according to the 
beta-actin expression.
RT-PCR analysis
Total RNA was extracted 
using Trizol (Invitrogen) 
according to the manufac-
turer’s instructions. RNA 
purity and concentration 
were determined by UV 
spectrophotometry at 
260nm. RNA was treated 
with RNase-free Dnase 
(RQ1 RNase-free Dnase, 
Promega), then reverse 
transcribed using oligo 
(dT) primers and reverse 
transcriptase (RevertAid™ 
Kit, Fermentas). The reac-
tion mixture (20µl) was 
incubated at 42°C for 60 
min, then 10 min at 70°C, 
and cooled on ice. RT-PCR 
was performed on result-
ing cDNA, using the manu-
facturer’s protocol, in a 
25µl reaction volume per 
Figure 2. Representative Western blot analyses and determination (mean and 
standard deviation) of F4/80 and TLR4 proteins expressions in fat tissue of 
the control (FC) and Crohn’s disease (FCD) groups, and in intestinal tissue of 
the control (IC) and Crohn’s disease (ICD) groups. For illustration purpose each 
line band represents one patient. For all conditions, n=10, *p<0.05 vs Control.
capillary. Gene-specific primers (Applied 
Biosystems™) were: Hs00152939 (TLR4); 
NM_002046.3 (GAPDH). RT-PCR amplification 
consisted of an initial denaturation step (50°C 
for 2 min and 95°C for 10 min), 40 cycles of 
denaturation (95°C for 15s), annealing (53°C 
for 20s) and extension (72°C for 20s), followed 
by a final incubation at 60°C for 1 min. All mea-
surements were normalized by the expression 
of GAPDH gene, considered as a stable house-
keeping gene. Gene expression was determined 
using the delta-delta Ct method: 2-▲▲CT 
(▲▲CT=[Ct(target gene) – Ct(GAPDH)]patient – 
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[Ct(target gene) – Ct(GAPDH)]control). Real-time 
data were analyzed using the Sequence 
Detector System 1.7 (Applied Biosystems).
Statistical analyses
Data were analyzed by t Test, comparing mes-
enteric fat tissue of CD group (FCD) and its 
respectively fat control group (FC); and compar-
ing, separately, intestinal tissue of CD group 
compared (p>0.05). Figure 4 illustrate these 
findings.
Discussion
The role of mesenteric fat tissue neighboring 
the intestinal area affected by CD remains 
unclear. There are few studies evaluating this 
question by analyzing biopsies of patients with 
CD and comparing to the samples of mesen-
Figure 3. Representative Western blot analyses and determination (mean and 
standard deviation) of IL-1β and IL-6 proteins expressions in fat tissue of the con-
trol (FC) and Crohn’s disease (FCD) groups, and in intestinal tissue of the control 
(IC) and Crohn’s disease (ICD) groups. For illustration purpose each line band rep-
resents one patient. For all conditions, n=10, *p<0.05 vs Control.
(ICD) and its respective-
ly intestinal control 
group (IC). The level of 
significance was set at 
p<0.05.
Results
Patients with CD had 
significantly higher lev-
els of TLR4 and F4/80 
(marker of macrophage 
activation) in intestinal 
mucosa (ICD) when 
compared to intestinal 
tissue control group (IC) 
(p<0.05). However, the 
comparison of local lev-
els of these proteins in 
mesenteric fat tissue of 
CD (FCD) and controls 
(FC) revealed that they 
were similar among the 
groups (p>0.05) (Figure 
2).
With regard to IL-1β and 
IL-6 expressions, there 
were higher levels in ICD 
group than in the con-
trol group (IC) (p<0.05). 
The expressions of the 
cytokines in mesenteric 
fat tissue were similar 
among the groups 
(p>0.05) (Figure 3).
TLR4 gene expression 
was lower in ICD group 
when compared to con-
trol (p<0.05), and no 
statistically significant 
differences were detect-
ed when the mesenteric 
fat tissue groups were 
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teric tissue of controls who were submitted to 
surgery for other reasons, excluding IBD. Most 
of these studies measured hormones released 
by the adipocytes, such as adiponectin and 
leptin, proinflammatory cytokines and growth 
factor expressions [22-25].
In this study, we evaluated the expression of 
proteins related to innate immune system, par-
ticularity the macrophage activation (F4/80) 
[26] and the ability of bacterial antigens recog-
nition (TLR4) [27] to evaluate these important 
aspects in intestinal and mesenteric fat tissue 
in patients with active CD, comparing to con-
trols. Indeed, we evaluated proinflammatory 
cytokines in the same conditions. Even noticed 
that was fat hypertrophy near to the intestinal 
affected area by CD during the surgical proce-
dure of all patients involved in this study, there 
were no difference of the evaluated proteins 
between mesenteric tissue of CD and the con-
trol. However, the protein expressions of F4/80 
and TLR4, but not in RNA expression to this 
receptor, were extremely higher in intestinal 
mucosa of CD group when compared to the 
control of terminal ileum.
This fact is interesting showing that there is up-
regulating of marker of macrophage activation 
and in protein translation of TLR4 in mucosa of 
CD, more importantly than in mesenteric fat tis-
sue. Probably, lamina propria cells in intestinal 
mucosa play a significant role in the beginning 
of this process in CD, leading the intestinal bar-
rier more responsive to bacterial antigens, due 
to up-regulation of membrane receptors, such 
as TLR4. The activation of macrophages in 
intestinal tissue of CD evaluated by F4/80 
expression, showed a concordance with what is 
described in previous work, that these cells are 
derived from plasma circulating monocytes, 
which differentiate in macrophage in the intes-
tinal lamina propria, when it remains [28, 29]. 
Conversely, the most important cell derived of 
monocytes in the mesenteric fat tissue is the 
dendritic cells, and macrophages are not seen 
in this tissue [30]. This could explain the similar 
expression of F4/80 in the mesenteric tissue 
groups. This difference between transcription 
and translation found in TLR4 is not very unusu-
al. One explanation is higher protein stability by 
protected ubiquitination becoming more stable 
and not being degraded. Furthermore, the pro-
inflammatory cytokines expressions were 
detected in mesenteric fat tissue, but were 
similar to the controls, showing that the most 
important inflammatory process occurs in 
intestinal mucosa.
Figure 4. Results of TLR4 gene expression, determined by RT-PCR. For FCD Group, n=10; for FC Group, n=8, *p<0.05 
vs control.
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Because disease whose etiology is not fully elu-
cidated, CD has been investigated in terms of 
molecular and genetic, in order to improve 
knowledge of the inflammatory pathways 
involved, and the mechanism of recognition of 
antigens in the intestinal lumen.
The present study shows that, even under 
inflammatory conditions, the mesenteric fat tis-
sue of CD patients presented similar expres-
sions of TLR4, F4/80 and pro-inflammatory 
cytokines, when compared with controls. It sug-
gests that primary defects of macrophage regu-
lation and response to bacterial antigens may 
occur in intestinal mucosa rather than in the 
adjacent fat tissue. The mesenteric fat tissue 
could play an important role in the maintenance 
of local inflammation in these patients; howev-
er, is needed more research to assess the influ-
ence of the mesenteric fat in CD and its asso-
ciation with the severe forms of disease as well 
as the role in its pathogenesis.
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